Every earnings call for ALIVUS — management tone, guidance, KPIs and promise tracking, quarter by quarter.
ALIVUS · 6 transcripts · Healthcare · latest Q4 FY26Revenue (FY26) ₹2,552 cr (+7% YoY); EBITDA (FY26) ₹858 cr (+20% YoY); EBITDA Margin (FY26) 33.6% (+4% YoY). Full year FY26 revenue stood at ₹2,552 crores, registering a 6.9% YoY growth.
Read full transcript & analysisRevenue ₹673 cr (+5% YoY); EBITDA Margin 36.4%; PAT ₹150 cr. Reported highest ever quarterly revenue of ₹673 crores, up 14.4% QoQ and 4.8% YoY.
Read full transcript & analysisRevenue ₹602 cr (+2% YoY); EBITDA Margin 30.1%; PAT ₹122 cr. Revenue reported at ₹602 crores, representing a 2.2% YoY growth.
Read full transcript & analysisRevenue ₹650 cr (+21% YoY); EBITDA Margin 32.1%; PAT ₹142 cr. Q4 Revenue reached ₹650 crores, representing a strong 21.1% YoY growth and 1.2% QoQ growth.
Read full transcript & analysisRevenue ₹642 cr (+12% YoY); EBITDA Margin 31.3% (+1% YoY); PAT ₹137 cr. Revenue of ₹642 crores, representing 12% YoY growth and 26.6% QoQ recovery.
Read full transcript & analysisRevenue ₹507 cr (−15% YoY); EBITDA Margin 28.2%; PAT ₹95 cr. Revenue from operations at ₹507 crores, down 14.9% YoY and 13.9% QoQ.
Read full transcript & analysis